Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Raymond James

Raymond James Lists Its Top Stock Picks In Online Ad

Raymond James hosted an online advertising conference call with an industry expert. The expert has visibility into ~$2 billion of spend with a mix similar to the ad industry and diversified across Fortune 1,000 advertisers.

Benzinga's Top Ratings Upgrades, Downgrades For June 17, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 17, 2022

Here's How Analysts View Braze Post Q1 Beat

Here's How Analysts View Braze Post Q1 Beat

Analysts acknowledged Braze, Inc's (NASDAQ:BRZE) Q1 beat amid macro headwinds. Piper Sandler analyst Brent Bracelin maintained Braze with an Overweight and cut the price target from $65 to $42 based on lower growth assumptions given increasing external risks. Despite increasing macro headwinds, BRZE delivered another strong quarter. Increasing investments in direct-to-consumer (DTC) and first-party data stacks have…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Read How Analysts Reacted To Devon Energy's RimRock Transaction

Mizuho Securities analyst Vincent Lovaglio raised the price target for Devon Energy Corp (NYSE:DVN) to $94 (an upside of 28%) from $92, reflecting the $865 million Rim Rock acquisition. The analyst states that the transaction adds 15kboed and 38k net acres to the company's existing 48kboed and 85k net acre Bakken position at ~4x free cash…

Target: 5 Analysts Cut Price Target After The Retailer Lowers Guidance

Target Corporation (NYSE: TGT) announced several initiatives on Tuesday to right-size its inventory, including order cancellations and slashing prices.

7 Coupa Software Analysts React To Q1 Earnings Beat: 'Lots Of Noise Around Billings'

Coupa Software Inc (NASDAQ: COUP) shares traded higher by 1.8% on Tuesday after the company reported strong earnings numbers and record subscription revenues in the first quarter.

Raymond James Lowers BRP Price Target As Supply Chain Snags

Raymond James analyst Joseph Altobello lowered the price target on BRP Inc (NASDAQ: DOOO) (TSX: DOO) to C$135 from C$146 and maintained a Strong Buy rating on the shares.

inkl

Read news from The Economist, FT, and more,
with one subscription

Key Takeaways From Raymond James' Initiation On DoorDash

Key Takeaways From Raymond James' Initiation On DoorDash

Raymond James analyst Aaron Kessler initiated coverage on DoorDash, Inc (NYSE:DASH) with a Market Perform rating with no price target. Kessler saw a large total addressable market for food delivery. DoorDash has established itself as the leading food delivery platform in the U.S. with a 50% plus market share, Kessler noted. DoorDash offered significant…

Spotify Shares Jump On Analyst Upgrade, Drawing Parallels With Netflix

Spotify Shares Jump On Analyst Upgrade, Drawing Parallels With Netflix

Raymond James analyst Andrew Marok upgraded Spotify Technology S.A. (NYSE:SPOT) to Outperform from Market Perform with a $150 price target. The stock has traded off significantly from all-time highs in early 2021 due to slower than expected scaling of the company's podcasting business and, most recently, soft margin guidance. Marok saw the bad news as…

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022

9 Salesforce Analysts React To Q1 Earnings Beat: 'Next Quality Software GARP Stock'

9 Salesforce Analysts React To Q1 Earnings Beat: 'Next Quality Software GARP Stock'

Salesforce Inc (NYSE: CRM) shares jumped Wednesday morning after the company reported first-quarter earnings and raised its profit forecast.

CD&R, TPG Take Covetrus Private In $4B Deal

CD&R, TPG Take Covetrus Private In $4B Deal

Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ:CVET) for $21.00 per share, representing an enterprise value of approximately $4 billion. CD&R and its affiliates currently beneficially own approximately 24% of the company's outstanding shares of common stock. The transaction…

A Warning Sign For Other Advertisers? Snapchat Analysts React To Shocking Guidance Cut, Stock Sell-Off

A Warning Sign For Other Advertisers? Snapchat Analysts React To Shocking Guidance Cut, Stock Sell-Off

Snap Inc (NYSE: SNAP) shares are plummeting 40% after CEO Evan Spiegel warned employees the company will miss its targets for revenue and earnings in the second quarter.

Raymond James View Skewed Scenarios On Absent Supportive Bid For This Animal Health Stock

Raymond James View Skewed Scenarios On Absent Supportive Bid For This Animal Health Stock

Raymond James downgraded the rating on Covetrus Inc (NASDAQ:CVET) from Outperform to Market Perform and removed the prior $22 price target after the company received a buyout at $21 per share. Though $21 may not ultimately prove to be the final resting place in terms of the offer price. Raymond James believes the proposed purchase…

Get all your
news in one place.

100’s of premium titles.
One news app.

Raymond James Is Bullish On CubeSmart, Public Storage - Read Why

Raymond James analyst Jonathan Hughes upgraded CubeSmart (NYSE:CUBE) from Outperform to Strong Buy and lowered the price target from $60 to $52 (24.6% upside). Hughes maintained Public Storage (NYSE:PSA) with a Strong Buy and lowered the price target from $375 to $365 (15.7% upside). The self-storage REITs were vulnerable to the recent sell-off despite the positive fundamental updates. They…

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022

5 Walmart Analysts React To Mixed Q1 Earnings: 'Particularly Attractive Buying Opportunity'

Walmart Inc (NYSE: WMT) shares were in the clearance aisle Wednesday after the company reported rising costs related to supply chain problems and inflation in the first quarter.

Check Out What Whales Are Doing With CVX

Someone with a lot of money to spend has taken a bullish stance on Chevron (NYSE:CVX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100’s of premium titles.
One news app.

Read Why Did Raymond James Slash Price Target On Inflarx

Raymond James remains a Strong Buy on Inflarx NV (NASDAQ: IFRX) following 1Q22 earnings based on a promising outlook for vilobelimab in Pyoderma Gangrenosum (PG) and potentially other indications. The biotech macro backdrop has forced many companies to be prudent with cash runway and prioritize clinical programs. InflaRx is also focusing on a potential pivotal trial…

Check Out What Whales Are Doing With CVX

Someone with a lot of money to spend has taken a bullish stance on Chevron (NYSE:CVX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Raymond James Maintains Outperform Rating for MeridianLink: Here's What You Need To Know

Raymond James has decided to maintain its Outperform rating of MeridianLink (NYSE:MLNK) and lower its price target from $27.00 to $21.00. Shares of MeridianLink are trading up 12.15% over the last 24 hours, at $16.25 per share.

Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022

Raymond James Sees 'Pipeline Key Success Factor' For This MedTech Stock

Raymond James has reiterated Outperform rating on LumiraDx Limited's (NASDAQ:LMDX) shares after 1Q revenue beat but lower than expected margins that ultimately do very little to impact long-term views of the company. They lowered the price target from $9 to $7. Revenues were 7% above Raymond James' view and 12% above consensus. The beat was…

Bumble Shares Soar On Analyst Confidence Post Q1 Beat

Analysts expressed optimism on Bumble Inc (NASDAQ: BMBL) post Q1 beat. Raymond James analyst Andrew Mar

Raymond James Says 'Supply Chain Challenges Made Q1 Messy' For This Medtech Stock

ICU Medical Inc (NASDAQ:ICUI) reported Q1 sales of $543.1 million vs. Raymond James' estimate of $530 million. Core ICU beat by $7 million, while newly acquired Smiths Medical missed by $5 million. With an Outperform rating, the analysts lowered the price target from $265 to $235. Adjusted EPS was $1.82, down from Raymond James' estimate…

People

Barton Crockett

Gregg Moskowitz

Patrick Walravens

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Bank of America

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

323,003 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play